The Priority Review

Tag

ceftobiprole

1 story

Stories

  1. Clinical trials

    ISTx registers Phase 3 trial of ceftobiprole in pediatric Staphylococcus aureus bacteremia

    The study, led by ISTx, LLC, plans to enroll 60 participants and begin on October 30, 2026, to compare ceftobiprole with standard-of-care antibiotics in children under 18 with Staphylococcus aureus bacteremia, including right-sided infective endocarditis. The trial will also evaluate safety, tolerability, efficacy, and pharmacokinetics of ceftobiprole.